| Market Indications | Pre-Clinical | Phase I | Phase II | Phase III |
|---|---|---|---|---|
|
Prostate Cancer
(NCT07457164)
|
Phase IIb Ongoing
|
Acute Urinary Retention
(NCT07733934)
|
Phase IIb Ongoing
|